Bath & Body Works (NYSE:BBWI – Get Free Report) had its price target boosted by research analysts at JPMorgan Chase & Co. from $35.00 to $39.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 10.36% from the stock’s previous close.
BBWI has been the subject of a number of other research reports. Wells Fargo & Company cut their price objective on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 6th. BMO Capital Markets reiterated an “outperform” rating and issued a $50.00 price target (down from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a report on Monday. The Goldman Sachs Group dropped their target price on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. Finally, Morgan Stanley reduced their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $42.44.
Read Our Latest Stock Analysis on BBWI
Bath & Body Works Price Performance
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. As a group, research analysts predict that Bath & Body Works will post 3.18 earnings per share for the current year.
Insider Activity at Bath & Body Works
In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.27% of the company’s stock.
Institutional Trading of Bath & Body Works
A number of hedge funds have recently made changes to their positions in the stock. Lone Pine Capital LLC increased its holdings in Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after buying an additional 1,547,399 shares during the last quarter. Anomaly Capital Management LP bought a new stake in shares of Bath & Body Works in the 2nd quarter valued at approximately $113,995,000. FMR LLC increased its holdings in shares of Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after acquiring an additional 2,501,828 shares during the last quarter. Sound Shore Management Inc. CT raised its position in shares of Bath & Body Works by 10.0% during the 2nd quarter. Sound Shore Management Inc. CT now owns 2,088,703 shares of the company’s stock valued at $81,564,000 after acquiring an additional 189,889 shares in the last quarter. Finally, KBC Group NV lifted its stake in Bath & Body Works by 9,023.5% during the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after purchasing an additional 1,683,160 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Stocks That Authorized $1 Billion Stock Buybacks to Boost Value
- How to Start Investing in Real Estate
- Pure Storage’s GenAI Pods and AI Trends Could Spark Recovery
- P/E Ratio Calculation: How to Assess Stocks
- Is Seaboard Corporation a Thanksgiving Feast for Investors?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.